Lumryz For Suspension, Extended Release
Product Images NDC 13551-003

Product Visual Gallery

This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Lumryz (NDC 13551-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avadel Cns Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (4.5g 30day Page 1)

Packaging label for Lumryz 4.5 g per packet oral suspension, extended release, containing sodium oxybate. The design includes dosage and storage instructions, manufacturer Avadel CNS Pharmaceuticals, LLC, and details a 30-packet carton for oral use only. The label shows Rx only and contains barcodes and regulatory information.*

FDA Label Image

Image Description (4.5g 7day Page 1)

Packaging label for Lumryz 4.5 g for packet, an extended-release oral suspension of sodium oxybate. The carton is manufactured for Avadel CNS Pharmaceuticals, LLC, Chesterfield, MO. The label includes dosage instructions, storage recommendations, and a barcode, with a predominantly gray and white design featuring the Lumryz name and Avadel logo.*

FDA Label Image

Image Description (6g 30day Page 1)

Packaging label for Lumryz 6 g per packet (sodium oxybate) for extended-release oral suspension. The design features an orange and white color scheme with dosage strength prominently displayed. Manufactured by Avadel CNS Pharmaceuticals, LLC, the label includes usage warnings, storage instructions, a barcode, and NDC 13551-002-30.*

FDA Label Image

Image Description (6g 7day Page 1)

Packaging carton label for Lumryz (sodium oxybate) extended-release oral suspension. The label indicates a 6 g per packet dosage strength and mentions it is for oral suspension use. Manufacturer is Avadel CNS Pharmaceuticals, LLC. Label includes dosage and storage instructions, a barcode, and regulatory details.*

FDA Label Image

Image Description (7.5g 30day Page 1)

Packaging label for Lumryz 7.5 g per packet, an extended-release oral suspension of sodium oxybate. The label shows the product name, strength, dosage form, and manufacturer Avadel CNS Pharmaceuticals, LLC. It includes directions about dosage, storage, a barcode, and regulatory information. The design features a blue section with white polka dots and text in black and white.*

FDA Label Image

Image Description (7.5g 7day Page 1)

Packaging label for Lumryz 7.5 g per packet, sodium oxybate extended-release oral suspension. The label includes dosing information, storage instructions, warnings, a barcode, and is manufactured by Avadel CNS Pharmaceuticals, LLC. The label is primarily turquoise with white and black text, and includes the proprietary name, generic name, and strength.*

FDA Label Image

Image Description (9g 30day Page 1)

The image shows a carton label for Lumryz 9 g per packet, an extended-release oral suspension of sodium oxybate. The label is primarily green and white, featuring the proprietary name Lumryz prominently and indicating it is Rx only. The label also includes storage instructions, a barcode, and the manufacturer Avadel CNS Pharmaceuticals, LLC, located in Chesterfield, MO. The carton contains 30 packets and 1 mixing cup, intended for single-patient use.*

FDA Label Image

Image Description (9g 7day Page 1)

Packaging label for Lumryz 9 g per packet (sodium oxybate) extended-release oral suspension by Avadel CNS Pharmaceuticals, LLC. The green and white label includes dosage information, storage instructions, and warnings. It also shows barcodes, NDC number 13551-004-07, and manufacturer details. The label indicates Rx only and a 9 g powder packet size.*

FDA Label Image

Image Description (Lumryz 01)

Chemical structure of sodium oxybate, depicting its molecular arrangement including sodium ion, carboxyl group, and hydroxyl group components.*

FDA Label Image

Image Description (Lumryz 10)

A highlighted text box emphasizing an important instruction: "Make sure to prepare LUMRYZ at bedside." This text is presented with 'Important:' in white font on a green background, followed by the instruction in black font on a white background.*

FDA Label Image

Image Description (Lumryz 11)

An illustration showing a bedside table with a lamp, a pair of scissors, a measuring cup marked with levels A and B, a foil packet, and a bottle containing liquid. The scene suggests preparation or administration of an oral suspension medication.*

FDA Label Image

Image Description (Lumryz 12)

Text panel instructing to mix the Lumryz solution at your bedside, likely part of preparation or administration instructions for Lumryz (sodium oxybate) oral extended release suspension.*

FDA Label Image

Image Description (Lumryz 13)

An instructional illustration showing one hand holding a bottle marked with levels A and B, while the other hand rotates or twists the cap indicated by an arrow, demonstrating how to open or close the bottle.*

FDA Label Image

Image Description (Lumryz 14)

An instructional illustration showing a hand pouring liquid from a bottle into a container with two labeled fill lines, A and B. The fill line A is indicated with an arrow and a label 'Fill Line A.' The image demonstrates proper dispensing volume guidance for a liquid medication suspension.*

FDA Label Image

Image Description (Lumryz 15)

An instructional illustration showing how to cut a pouch along a designated cutting line using scissors. The diagram depicts one hand holding the pouch and another hand operating scissors to slice through the marked line.*

FDA Label Image

Image Description (Lumryz 16)

FDA Label Image

Image Description (Lumryz 17)

An instructional illustration showing hands demonstrating how to tear a sealed packet along a designated tear mark. The image highlights the tear mark with an arrow and step-by-step hand positioning for opening the package.*

FDA Label Image

Image Description (Lumryz 18)

An instructional illustration showing a hand pouring granular powder from a packet into a small measuring cup held by another hand. The cup is marked with measurement lines labeled 'A' and 'B.' This image likely depicts preparation steps for an oral suspension medication.*

FDA Label Image

Image Description (Lumryz 19)

An instructional illustration showing a hand gripping a bottle of Lumryz oral suspension and turning its child-resistant cap to the left (counterclockwise) to open. Two measurement marks labeled A and B on the bottle are visible below the cap.*

FDA Label Image

Image Description (Lumryz 2)

The image shows an instructions for use panel for Lumryz (sodium oxybate) extended-release oral suspension. It indicates dosing as one packet per dose and includes the Avadel logo.*

FDA Label Image

Image Description (Lumryz 20)

An instructional illustration showing a hand shaking a medication bottle marked with levels A and B. An arrow indicates shaking motion back and forth for 60 seconds, emphasizing proper suspension of the extended-release oral formulation.*

FDA Label Image

Image Description (Lumryz 21)

An instructional illustration showing a hand holding a small bottle with liquid. The bottle has a label with two marked fill lines labeled 'A' and 'B,' indicating different liquid volume levels inside the bottle.*

FDA Label Image

Image Description (Lumryz 22)

A text panel instructing to take the Lumryz solution at your bedside, indicating guidance related to the use of Lumryz (sodium oxybate) oral extended-release suspension.*

FDA Label Image

Image Description (Lumryz 23)

An instructional illustration showing a hand twisting to open the child-resistant safety cap of a medication container, while the other hand holds the bottle. The bottle has visible fill level markings labeled A and B.*

FDA Label Image

Image Description (Lumryz 24)

An illustration showing a person drinking from a small cup marked with measurement lines labeled A and B, demonstrating the oral administration of a liquid medication dose.*

FDA Label Image

Image Description (Lumryz 25)

An instructional illustration showing a hand holding a measuring cup with two fill lines labeled A and B. Liquid is being poured from a container into the cup, filling it to line B.*

FDA Label Image

Image Description (Lumryz 26)

An instructional illustration showing a hand gripping a small cup labeled with volume markers 'A' and 'B'. A second hand is twisting or opening the cap of the cup, indicated by an orange arrow pointing counterclockwise. This likely demonstrates how to open the medication measuring cup for Lumryz oral suspension.*

FDA Label Image

Image Description (Lumryz 27)

An instructional illustration depicting a hand shaking a bottle with a label marked "A" for 10 seconds, indicated by a stopwatch icon. The image suggests shaking the oral suspension bottle before use, with an arrow showing the shaking motion.*

FDA Label Image

Image Description (Lumryz 28)

An instructional illustration showing two hands opening a container: one hand grips the container while the other hand twists the cap counterclockwise, indicated by a yellow arrow. The container has two level markers labeled A and B visible on its side.*

FDA Label Image

Image Description (Lumryz 29)

An instructional illustration showing a person drinking from a measuring cup labeled with measurement marks 'A' and 'B'. The image likely demonstrates how to properly measure and take the oral suspension of Lumryz, sodium oxybate extended-release.*

FDA Label Image

Image Description (Lumryz 3)

A text panel titled "Important information when taking LUMRYZ" addressing key safety and usage information for the sodium oxybate oral extended-release suspension product Lumryz. The panel likely contains warnings, precautions, or instructions for patients and healthcare providers.*

FDA Label Image

Image Description (Lumryz 30)

An instructional illustration showing a bedside table with a lamp, a pair of scissors, a clear bottle, a measuring cup marked with 'A' and 'B', and a sealed pouch. The image appears to depict supplies and steps related to preparing or administering oral suspension.*

FDA Label Image

Image Description (Lumryz 31)

FDA Label Image

Image Description (Lumryz 32)

This text panel provides disposal instructions for Lumryz (sodium oxybate) extended-release oral suspension. It addresses how to properly throw away or dispose of the medication, focusing on safe handling and disposal practices for this prescription drug by Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Lumryz 33)

Black and white instructional illustration showing a hand discarding a partially torn sachet or packet into a trash can. The setting appears to be a corner near a wall and a countertop or table edge.*

FDA Label Image

Image Description (Lumryz 34)

An instructional illustration showing a hand holding a measuring cup under a running faucet, filling the cup with liquid. The image is likely intended to demonstrate the step of measuring or preparing a liquid medication dose.*

FDA Label Image

Image Description (Lumryz 35)

An instructional illustration showing a hand discarding a bottle into a trash bin, likely indicating proper disposal of medication packaging or container for Lumryz (sodium oxybate) extended-release oral suspension.*

FDA Label Image

Image Description (Lumryz 36)

Label for Lumryz (sodium oxybate) extended-release oral suspension showing dosing as 1 packet per dose. Manufactured for Avadel CNS Pharmaceuticals, LLC, Chesterfield, MO, USA. Label includes the Avadel logo.*

FDA Label Image

Image Description (Lumryz 4)

Lumryz packaging and contents image showing the carton and a bottle of Lumryz oral extended-release suspension. Lumryz contains sodium oxybate and is labeled for prescription use. The image displays product packaging with the brand name prominently and a bottle with a white cap alongside the carton, manufactured by Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Lumryz 5)

An illustration depicting the packaging and components of Lumryz (sodium oxybate) extended-release oral suspension. It shows an open carton containing multiple individual packets sealed with a tamper-evident seal. A separate mixing cup is labeled with fill lines A and B. The back of a packet includes an expiration date (EXP). The labeler is Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Lumryz 6)

An instructional illustration showing two items: a glass or bottle of water on the left and a pair of scissors on the right, labeled as optional. The image likely supports preparation or administration instructions for the medication Lumryz oral suspension.*

FDA Label Image

Image Description (Lumryz 7)

A text panel titled 'How should I store LUMRYZ?' providing storage instructions for Lumryz (sodium oxybate) extended-release oral suspension. The panel addresses proper storage methods for the medication but the full instructions are not visible.*

FDA Label Image

Image Description (Lumryz 8)

A text image titled 'Before using LUMRYZ,' likely introducing instructions or information related to the sodium oxybate extended-release oral suspension product Lumryz by Avadel CNS Pharmaceuticals.*

FDA Label Image

Image Description (Lumryz 9)

A text panel titled 'Before each use' showing instructions or information related to the preparation or administration of the product. The text is in blue font on a white background, indicating a section likely advising on steps to take prior to using the medication.*

FDA Label Image

Image Description (Packet 4.5g)

Packaging label for Lumryz (sodium oxybate) extended-release oral suspension, showing multiple packets each containing 4.5 g of sodium oxybate equivalent to 3.731 g of oxybate. The label states the product is for oral use only, with dosage instructions indicating one packet per day at bedtime. The labeler is Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Packet 6g)

Packaging label for Lumryz 6 g per packet, an extended-release oral suspension of sodium oxybate. The label shows multiple packet panels with dosage strength, usage instructions indicating oral use only, and warnings to take only one packet per day at bedtime. Labeler is Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Packet 7.5g)

Lumryz 7.5 g for packet sodium oxybate extended-release oral suspension label. The label displays repeated sections with dosage strength, warnings, and barcodes on a blue background with white and gray dotted accents. The product is labeled for oral use only and includes manufacturer information from Avadel CNS Pharmaceuticals, LLC.*

FDA Label Image

Image Description (Packet 9g)

Packaging label for Lumryz (sodium oxybate) extended-release oral suspension, 9 g per packet, from Avadel CNS Pharmaceuticals, LLC. The label features a green and white design with dosage information and usage instructions indicating oral use only. Multiple packet labels are shown in a row for packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.